BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22407764)

  • 1. The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer.
    Romero OA; Setien F; John S; Gimenez-Xavier P; Gómez-López G; Pisano D; Condom E; Villanueva A; Hager GL; Sanchez-Cespedes M
    EMBO Mol Med; 2012 Jul; 4(7):603-16. PubMed ID: 22407764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization of retinoids and corticoids to epigenetic drugs in MYC-activated lung cancers by antitumor reprogramming.
    Romero OA; Verdura S; Torres-Diz M; Gomez A; Moran S; Condom E; Esteller M; Villanueva A; Sanchez-Cespedes M
    Oncogene; 2017 Mar; 36(9):1287-1296. PubMed ID: 27593925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRG1 and BRM function antagonistically with c-MYC in adult cardiomyocytes to regulate conduction and contractility.
    Willis MS; Holley DW; Wang Z; Chen X; Quintana M; Jensen BC; Tannu M; Parker J; Jeyaraj D; Jain MK; Wolfram JA; Lee HG; Bultman SJ
    J Mol Cell Cardiol; 2017 Apr; 105():99-109. PubMed ID: 28232072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1.
    Romero OA; Torres-Diz M; Pros E; Savola S; Gomez A; Moran S; Saez C; Iwakawa R; Villanueva A; Montuenga LM; Kohno T; Yokota J; Sanchez-Cespedes M
    Cancer Discov; 2014 Mar; 4(3):292-303. PubMed ID: 24362264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.
    Shi J; Whyte WA; Zepeda-Mendoza CJ; Milazzo JP; Shen C; Roe JS; Minder JL; Mercan F; Wang E; Eckersley-Maslin MA; Campbell AE; Kawaoka S; Shareef S; Zhu Z; Kendall J; Muhar M; Haslinger C; Yu M; Roeder RG; Wigler MH; Blobel GA; Zuber J; Spector DL; Young RA; Vakoc CR
    Genes Dev; 2013 Dec; 27(24):2648-62. PubMed ID: 24285714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells.
    Medina PP; Carretero J; Ballestar E; Angulo B; Lopez-Rios F; Esteller M; Sanchez-Cespedes M
    Hum Mol Genet; 2005 Apr; 14(7):973-82. PubMed ID: 15731117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Casein kinase 2-mediated phosphorylation of Brahma-related gene 1 controls myoblast proliferation and contributes to SWI/SNF complex composition.
    Padilla-Benavides T; Nasipak BT; Paskavitz AL; Haokip DT; Schnabl JM; Nickerson JA; Imbalzano AN
    J Biol Chem; 2017 Nov; 292(45):18592-18607. PubMed ID: 28939766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
    Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T
    Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SWI/SNF chromatin remodeling complex regulates myocardin-induced smooth muscle-specific gene expression.
    Zhou J; Zhang M; Fang H; El-Mounayri O; Rodenberg JM; Imbalzano AN; Herring BP
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):921-8. PubMed ID: 19342595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer.
    Medina PP; Sanchez-Cespedes M
    Epigenetics; 2008; 3(2):64-8. PubMed ID: 18437052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAF60A mediates interactions between the microphthalmia-associated transcription factor and the BRG1-containing SWI/SNF complex during melanocyte differentiation.
    Aras S; Saladi SV; Basuroy T; Marathe HG; Lorès P; de la Serna IL
    J Cell Physiol; 2019 Jul; 234(7):11780-11791. PubMed ID: 30515787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
    Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
    Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.
    Keenen B; Qi H; Saladi SV; Yeung M; de la Serna IL
    Oncogene; 2010 Jan; 29(1):81-92. PubMed ID: 19784067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat shock transcription factor (Hsf)-4b recruits Brg1 during the G1 phase of the cell cycle and regulates the expression of heat shock proteins.
    Tu N; Hu Y; Mivechi NF
    J Cell Biochem; 2006 Aug; 98(6):1528-42. PubMed ID: 16552721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function.
    Cheng SW; Davies KP; Yung E; Beltran RJ; Yu J; Kalpana GV
    Nat Genet; 1999 May; 22(1):102-5. PubMed ID: 10319872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel role of Brg1 in the regulation of SRF/MRTFA-dependent smooth muscle-specific gene expression.
    Zhang M; Fang H; Zhou J; Herring BP
    J Biol Chem; 2007 Aug; 282(35):25708-16. PubMed ID: 17599918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex.
    Wang X; Sansam CG; Thom CS; Metzger D; Evans JA; Nguyen PT; Roberts CW
    Cancer Res; 2009 Oct; 69(20):8094-101. PubMed ID: 19789351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
    Schallenberg S; Bork J; Essakly A; Alakus H; Buettner R; Hillmer AM; Bruns C; Schroeder W; Zander T; Loeser H; Gebauer F; Quaas A
    BMC Cancer; 2020 Jan; 20(1):12. PubMed ID: 31906887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NPM and BRG1 Mediate Transcriptional Resistance to Retinoic Acid in Acute Promyelocytic Leukemia.
    Nichol JN; Galbraith MD; Kleinman CL; Espinosa JM; Miller WH
    Cell Rep; 2016 Mar; 14(12):2938-49. PubMed ID: 26997274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chromatin remodeler Brg1 activates enhancer repertoires to establish B cell identity and modulate cell growth.
    Bossen C; Murre CS; Chang AN; Mansson R; Rodewald HR; Murre C
    Nat Immunol; 2015 Jul; 16(7):775-84. PubMed ID: 25985234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.